Home › Funds › Silverberg Bernstein Capital Management LLC › SOPH

Silverberg Bernstein Capital Management LLC position in SOPH

SOPHIA GENETICS SA · Technology

Silverberg Bernstein Capital Management LLC reported holding 77,989 shares of SOPH (SOPHIA GENETICS SA) in its Q3 2026 13F filing — a position valued at US$654K, representing 0.31% of its reported portfolio and ranking #41 among its reported holdings. Silverberg Bernstein Capital Management LLC has disclosed SOPH holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)77.99K sh
Reported value held$653.55K
Portfolio Weight0.31%
First reportedQ4 2024
Last changeAdd
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How Silverberg Bernstein Capital Management LLC's SOPH position evolved

Silverberg Bernstein Capital Management LLC first disclosed a stake in SOPH in Q4 2024 at 22,464 shares (US$70K). The position peaked in Q3 2026 at 77,989 shares, worth US$654K. Across 8 filings, Silverberg Bernstein Capital Management LLC increased the stake 7 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 77,989 shares valued at US$654K — an increase of 11,120 shares quarter over quarter.. Notable position changes include a 54% increase in Q1 2025 (shares fell 7% over the following quarter), a 32% increase in Q2 2025 (shares rose 54% over the following quarter), a 29% increase in Q2 2026 (shares rose 45% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 22.46K $70.09K New
Q1 2025 34.67K $115.12K Add
Q2 2025 45.72K $141.72K Add
Q3 2025 46.72K $222.36K Add
Q4 2025 47.81K $223.30K Add
Q1 2026 51.97K $257.25K Add
Q2 2026 66.87K $385.83K Add
Q3 2026 77.99K $653.55K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SOPH and 13F data

SOPH (SOPHIA GENETICS SA) is a Technology company. 60 other funds we track also report a position in SOPH — the largest reported positions include GENERATION INVESTMENT MANAGEMENT LLP (US$39.2M), AIGH Capital Management LLC (US$22.8M), AKRE CAPITAL MANAGEMENT LLC (US$21.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SOPH

All SOPH fund holders →

FAQ

How long has Silverberg Bernstein Capital Management LLC held SOPH?

Silverberg Bernstein Capital Management LLC has disclosed SOPH holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Silverberg Bernstein Capital Management LLC's current position in SOPH?

As of Q3 2026, Silverberg Bernstein Capital Management LLC holds 77.99K shares of SOPH (SOPHIA GENETICS SA), valued at $653.55K, representing 0.31% of its reported portfolio and ranking #41.

Has Silverberg Bernstein Capital Management LLC been buying or selling SOPH?

In the latest 13F filing (Q3 2026), Silverberg Bernstein Capital Management LLC increased its position in SOPH. The position peaked in Q3 2026 at 77.99K shares.

Which other funds hold SOPH?

Other major institutional holders of SOPH include GENERATION INVESTMENT MANAGEMENT LLP, AIGH Capital Management LLC, AKRE CAPITAL MANAGEMENT LLC, among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.